EMCDDA Home
  • EN
Search

Table DUP-2. Prevalence of lifetime injecting drug use among prisoners, 2000–09

CountryYearSource/ref. (1)Definition and methodological comments (2)Drug used
(and if any: restriction on base population)Note% IDU
Belgium20062Persons reporting lifetime injecting drug use. Comment: national survey in all the 32 Belgian prisons in a representative sample of 10% of adult prisoners, including remanded, sentenced and mentally disordered prisoners, both males and females (n = 902).any illicit drug18
20033Persons reporting injecting drug use (prior/within prison). Comment: survey in a random sample of 10 prisons (over a total of 38) amongst on remand, convicted and social defence (psychiatric cases) prisoners (n= 886).any illicit drug15
Bulgaria20091Persons reporting at admission to the prison ever injecting drug use prior to imprisonment Comment: national survey in 17 remand prisons among all convicted, defendant adults and detained persons in prison and remand arrest during the year (n= 5776)heroin7
20062Persons registered (in the judicial and medical files) as lifetime injecting drug users prior to imprisonment (self-report). Comment: national survey in 6 prisons among on remand detainees (n= 3733). any illicit drug7
20062Persons registered (in the judicial and medical files) as lifetime injecting drug users prior to imprisonment (self-report). Comment: national survey in 17 prisons among on remand detainees (n= 7274). cocaine0.04
heroin4
amphetamines0.03
ecstasy0.01
20046Persons in contact with health services, psychologists and social workers reporting lifetime injecting drug use prior to imprisonment. Comment: national survey in all prisons in Bulgaria (n= 11521).any illicit drug(4)2
heroin(4)1
other drugs than heroin(4)0.9
Germany20071Persons reporting lifetime injecting drug use prior to imprisonment. Comment: survey in 6 prisons in 3/16 federal states in a quota sample of on remand and convicted prisoners (n= 1457)any illicit drug31
Spain20061Persons reporting injecting lifetime drug use prior to imprisonment Comment: nationwide survey in 66 prisons in a random sample of prisoners (n= 4934) (women overrepresented).any illicit drug26
France20031Persons reporting lifetime injecting drug use. Comment: nationwide survey in 134 prisons (out of 187) among a representative sample of on remand and convicted Persons entering prison (n= 6087).7
Italy2001-0212Persons reporting a history of injecting drug use. Comment: cross-sectional survey in a convenience sample of males and females in 8 prisons in different areas of Italy (n = 973).any illicit drugs30
Latvia20031Persons reporting lifetime injecting drug use prior to imprisonment. Comment: national survey in 11 (out of 15) prisons with at least 100 convicted persons (n= 2867).20
Hungary20081persons reporting lifetime injecting drug use prior to imprisonment Comment: national cross-sectional survey in 22 prisons amongst a proportional random sample of adult both males and females convicted prisoners of Hungarian citizenship (n= 503)any illicit drug10
20042Persons reporting injecting drug use prior to imprisonment. Comment: national survey in 11 prisons amongst a proportional random sample of adult male convicted prisoners of Hungarian citizenship (n= 609).any illicit drug (adult males)7
20042Persons reporting injecting drug use (both prior to and in prison). Comment: national survey in 11 prisons amongst a proportional random sample of adult male convicted prisoners of Hungarian citizenship (n= 609).any illicit drug (adult males)8
Poland20012Persons reporting lifetime injecting drug use prior to imprisonment. Comment: nationwide survey (38 prisons) in a random sample of on remand and convicted adult male prisoners (n= 1189)any illicit drug (adult males)6
Portugal20071Persons reporting lifetime injecting drug use prior to imprisonment. Comment: nationwide survey (44 prisons) in a random sample of on remand and convicted prisoners (n= 1986).Cocaine12
Heroin13
20071Persons reporting lifetime injecting drug use prior/within prison. Comment: nationwide survey (44 prisons) in a random sample of on remand and convicted prisoners (n= 1986).any illicit drug 21
20012Persons reporting lifetime injecting drug use prior to imprisonment. Comment: nationwide survey (47 prisons) in a random sample of on remand and convicted prisoners (n= 2057).any illicit drug 27
Romania20061Persons reporting lifetime injecting drug use prior/within prison. Comment: survey in 27 prisons among prisoners (n=3218) any illicit drug 6
United Kingdom (England)2004-051Women reporting lifetime injecting drug use. Comment: survey in 2 remand prisons for women among all new receptions during certain pre-defined periods (n = 505).any illicit drug (females)38
United Kingdom (England)20012women reporting having ever injected drugs. Comment: national survey of female prisoners on remand and convicted in 10 prisons (n= 301). (from Borrill et al., 2003a).any illicit drug (females)31
United Kingdom (England)20012Women reporting having injected drugs outside prison only. Comment: national survey of female prisoners on remand and convicted in 10 prisons (n= 301). (from Borrill et al., 2003a).any illicit drug (females)29
Croatia20091persons reporting lifetime injecting drug use prior to imprisonment Comment: survey among attendees to the depapartment for diagnostics and programming, who had been convicted and still have more than six months of servitude, regardless on his/hers gender and age (n= 1916)any illicit drug5
cocaine0.7
heroin5

Notes:

 n.a.: not available. 

 (2) Caution should be applied when considering that a survey is said to be 'national' as this refers to its intended geographical coverage, but does not mean it is necessarily representative of the national situation, which would depend on any sampling procedures adopted. Note that the size of the prison population surveyed is not available for most of the studies displayed in this table, and sample sizes reflect different proportions of the population in different countries. 

 (4) Bulgaria: due the fear of sanction it is likely that drug use is under-reported. 

Sources:

 (1) For access to sources and bibliographic references, refer to Table DUP-0.  

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Thursday, 23 June 2011